Evaluation of the Ambu ® aScope® for Tracheal Intubation in Difficult Airways

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Patrick Schoettker,MD PD, University of Lausanne Hospitals
ClinicalTrials.gov Identifier:
NCT01467739
First received: November 8, 2011
Last updated: December 13, 2013
Last verified: December 2013
  Purpose

The purpose of this study is to evaluate a disposable fiberscope (Ambu ® aScope®) for tracheal intubation in difficult airways due to cervical immobilization by a cervical collar, and compare it to a conventional reusable fiberscope.


Condition Intervention
Surgical Intervention
Endotracheal Intubation
Device: Ambu ® aScope®
Device: a conventional reusable fiberscope

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Evaluation of the Ambu ® aScope® for Tracheal Intubation During Cervical Spine Immobilization With a Cervical Collar, in Comparison With a Conventional Reusable Fiberscope.

Further study details as provided by University of Lausanne Hospitals:

Primary Outcome Measures:
  • Effectiveness of the Ambu ® aScope® for tracheal intubation in difficult airways. [ Designated as safety issue: Yes ]
    Time to reach the carina and Time to obtain an end tidal CO2 curve by aScope in comparison to conventional reusable fiberscope.


Enrollment: 100
Study Start Date: June 2011
Study Completion Date: November 2011
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Ambu ® aScope® Device: Ambu ® aScope®
Active Comparator: a conventional reusable fiberscope. Device: a conventional reusable fiberscope

Detailed Description:

Any general anesthesia requiring tracheal intubation for controlled ventilation includes the likelihood of intubation failure and, in case of difficult or impossible mask ventilation, can be life-threatening. In patients with diagnosed or suspected disease of the cervical spine, airway control can be tricky. Indeed, the cervical collar used to secure the cervical spine makes direct laryngoscopy impossible. In elective surgery, the most commonly used technique is fiberoptic intubation, achievable without removing of the cervical collar.

A new disposable fiberscope was recently developed by Ambu ®: the aScope®. It consists of a disposable flexible fiberscopic device, whose distal end is fitted with a camera that can be directed. This device is connected to a separate reusable LCD display. The aScope® is used as a conventional flexible fiberscope to guide the instrumentation of the airway.

With the exception of case reports, all studies of this device in difficult conditions were performed on mannequins.

The investigators propose to assess and validate this device on real patients with difficult airways caused by a rigid cervical collar and compare intubation conditions and time to the gold standard technique, the classical reusable fiberscope.

Induction of general anesthesia is performed by the anesthesiologist responsible for the patient, according to the standards in the anesthesiology department.

The cervical collar is fitted and positioned once the patient is asleep in addition to a dedicated oropharyngeal cannula (Ovassapian fiberoptic intubating airway cannula) in order to guide the aScope® or fiberscope in the oropharynx. The timer is activated once the investigating physician takes the aScope® or fiberscope in his hands. The device is advanced into the airway with visual control on the LCD screen for the aScope® or on an external dedicated screen for the fiberscope. Once in the trachea, the device will serve as a guide for introduction of the orotracheal tube, according to standard fiberscopic intubation technique. Tracheal intubation is confirmed through visualization of the distal end of the tube into the trachea, the onset of an end tidal CO2 curve and auscultation. The timer will be stopped at the onset of the end tidal CO2 curve.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients older than 16 years
  • ASA 1-2
  • BMI < 35 kg/m2
  • Surgery requiring general anesthesia with intubation of the trachea

Exclusion Criteria:

  • Emergency operation
  • Patient ASA 3 or more
  • BMI above 35 kg/m2
  • History of difficult airways
  • History of surgery or radiotherapy in head and neck
  • Presence of gastro esophageal reflux
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01467739

Locations
Switzerland
University of Lausanne Hospitals
Lausanne, Vaud, Switzerland, 1011
Sponsors and Collaborators
University of Lausanne Hospitals
  More Information

Publications:
Responsible Party: Patrick Schoettker,MD PD, MD, University of Lausanne Hospitals
ClinicalTrials.gov Identifier: NCT01467739     History of Changes
Other Study ID Numbers: 88/11
Study First Received: November 8, 2011
Last Updated: December 13, 2013
Health Authority: Switzerland: Federal Office of Public Health

ClinicalTrials.gov processed this record on October 21, 2014